Explore
NASH and Systemic Complications
0 Ungluers have
Faved this Work
Login to Fave
Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH). NASH is a chronic inflammatory condition of the liver that can further progress to fibrosis and cirrhosis, which may eventually lead to liver failure and death. While we have increased our mechanistic knowledge regarding the pathogenesis of NASH within the last decade, treatment options are still limited and liver biopsies have remained the gold standard for diagnosis. To achieve major clinical breakthroughs for NASH patients, it is not sufficient to use a single animal model, since each model has specific limitations. Furthermore, we should rely more on alternative models such as organ-on-a-chip, which will enable us to explore unknown aspects of disease pathogenesis much faster and serve as clinically relevant surrogates for murine models. Another important direction for the improvement of patient health is to pay more attention to extrahepatic, organ-specific and systemic effects, which are associated with NASH. The articles in this Special Issue include an up-to-date overview of the rapidly developing technologies, novel targets for intervention and insights in the field in NASH. Additionally, these articles describe the major challenges in the field, strategies to overcome them and suggestions for future directions. To improve patient’s outcome, clinicians, as well as scientists with biomedical, nutrition, physics and mathematics backgrounds, should join forces. Although challenges remain, the future of the field seems promising as these novel technologies and developments are expected to lead to progress in NASH.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 61 times via unglue.it ebook links.
- 61 - pdf (CC BY) at Unglue.it.
Keywords
- Adaptive Immune system
- Alzheimer’s disease
- aminopyrine
- artificial intelligence
- breath test
- cardiovascular diseases (CVD)
- cognitive impairment
- controlled attenuation parameter
- extra-hepatic outcome
- extracellular vesicles
- fatty liver
- fecal microbiota transplantation
- GLP-1 agonist
- hepatocellular carcinoma
- Hypertension
- Innate immune system
- insulin resistance (IR)
- intestinal permeability
- Leptin
- Liver disease
- liver function
- liver steatosis
- liver stiffness
- magnesium (Mg2+)
- memory dysfunction
- Mesenchymal Stromal Cells
- metabolic syndrome
- microbiota
- microsomal
- mouse models
- MR spectroscopy
- MRI PDFF
- multifactorial disease
- n/a
- NAFLD
- NASH
- neurodegeneration
- non-alcoholic fatty liver disease
- non-alcoholic steatohepatitis
- non-alcoholic steatohepatitis (NASH)
- nonalcoholic fatty liver disease
- nonalcoholic steatohepatitis
- Obesity
- organ-on-a-chip
- organelle transfer
- Pathogenesis
- physical exercise
- primary hepatocytes
- Probiotics
- Reference, information & interdisciplinary subjects
- Research & information: general
- SGLT-2 inhibitor
- steatohepatitis
- transient elastography
- translational value
- tunneling nanotubes (TNTs)
- type 2 diabetes
- type 2 diabetes mellitus (T2DM)
Links
DOI: 10.3390/books978-3-0365-2979-0Editions